Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian Population [0.03%]
一项针对意大利人群银屑病患者的药物利用分析回顾性研究
Valentina Perrone,Serena Losi,Silvia Sabatino et al.
Valentina Perrone et al.
Purpose: An Italian real-world retrospective study was conducted in patients with psoriasis (PSO) to evaluate their characteristics, treatment patterns, and biological/targeted synthetic disease-modifying antirheumatic dr...
Assessment of Vitamin D Level in Patients with Psoriasis and Its Correlation with Disease Severity: A Case-Control Study [0.03%]
银屑病患者维生素D水平及其与疾病严重程度相关性的病例对照研究
Ranju Pokharel,Sudha Agrawal,Prajwal Pandey et al.
Ranju Pokharel et al.
Background: Chronic plaque psoriasis is a chronic inflammatory skin disorder. Vitamin D has been shown to have effects on keratinocyte differentiation as well as immune regulation in the skin. ...
Elisa Camela,Luca Potestio,Angelo Ruggiero et al.
Elisa Camela et al.
Although innovative targeted therapies have positively revolutionized psoriasis treatment shifting treatment goals to complete or almost complete skin clearance, primary or secondary lack of efficacy is still possible. Hence, identifying ro...
Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients [0.03%]
印度皮肤病学家和患者银屑病治疗惰性的量化调查研究
Murlidhar Rajagopalan,Sunil Dogra,Kiran Godse et al.
Murlidhar Rajagopalan et al.
Purpose: The primary objective of the study was to understand the therapeutic inertia in treatment and management of plaque psoriasis among dermatologists, along with determining the preferred treatment choices for manage...
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis [0.03%]
减少银屑病患者发生银屑病关节炎的风险
Paolo Gisondi,Francesco Bellinato,Martina Maurelli et al.
Paolo Gisondi et al.
Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory arthritis associated with psoriasis, which may manifest with different domains such as dactylitis, enthesitis, synovitis and spondylitis. The estimated prevalence of PsA in p...
Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study [0.03%]
古塞库单抗治疗中重度银屑病长期疗效和安全性的3年真实世界回顾性研究
Matteo Megna,Luca Potestio,Gabriella Fabbrocini et al.
Matteo Megna et al.
Introduction: Guselkumab safety and efficacy profiles in psoriasis have been showed by VOYAGE (1 and 2) trials. Although trial results have been already previously confirmed by real-life studies, long-term real-life data,...
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study [0.03%]
用于儿科和老年人群银屑病治疗的抗TNF类似药的有效性和安全性：一项为期72周的回顾性研究
Matteo Megna,Luigi Fornaro,Luca Potestio et al.
Matteo Megna et al.
Purpose: To determine the efficacy and safety of adalimumab (ADA) and etanercept (ETA) biosimilars in elderly and children with psoriasis. Methods: ...
Samuel Yeroushalmi,Marwa Hakimi,Mimi Chung et al.
Samuel Yeroushalmi et al.
Psoriasis is a prevalent inflammatory skin disorder that is associated with a number of comorbidities including cardiovascular disease and metabolic syndrome. Exercise can influence the outcomes of chronic inflammatory diseases, and the pre...
Erratum: Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management [Corrigendum] [0.03%]
银屑病生物制剂长期安全性和风险管控的更新观点致错刊公告
[This corrects the article DOI: 10.2147/PTT.S328575.]. © 2022 Al-Janabi et al.
Published Erratum
Psoriasis (Auckland, N.Z.). 2022 Jul 1:12:187-188. DOI:10.2147/PTT.S380486 2022
Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience [0.03%]
富马酸二甲酯治疗中重度银屑病的疗效分析
Pau Rosés Gibert,Francisco Javier de la Torre Gomar,Amaia Saenz Aguirre et al.
Pau Rosés Gibert et al.
Purpose: Dimethyl fumarate (DMF) is an oral formulation approved for the treatment of moderate-to-severe psoriasis in adult patients requiring systemic therapy. Here, we describe our clinical experience with DMF for moder...